Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Capital/Financing Update 2005

Mar 23, 2005

6990_rns_2005-03-23_01a0cfa9-805f-4d77-943e-ded4b5752b64.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

8-K 1 f8k032305.htm MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation"

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation"

FORM 8-K

MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Workstation"

CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Workstation"

Date of Report (Date of earliest event reported) January 4, 2005

MARKER FORMAT-SHEET="Head Minor Center-TNR" FSL="Workstation"

PLURISTEM LIFE SYSTEMS, INC. (Exact name of registrant as specified in its charter)

MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation"

Nevada (State or other jurisdiction of incorporation)

MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation"

001-31392 (Commission File Number)

MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation"

98-0351734 (IRS Employer Identification No.)

MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation"

MATAM Advanced Technology Park, Building No. 20, Haifa, Israel 31905 (Address of principal executive offices and Zip Code)

MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation"

011-972-4-850-1080 Registrant’s telephone number, including area code

MARKER FORMAT-SHEET="Head Left-TNR" FSL="Workstation"

Not Applicable (Former name or former address, if changed since last report)

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Default"

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation"

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation"

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation"

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation"

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

MARKER FORMAT-SHEET="Head Major Left Bold-TNR" FSL="Workstation"

Item 3.02. Unregistered Sales of Equity Securities

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation"

The board of directors of our company approved the issuance of 2,400,000 shares of our common stock and the issuance of 2,400,000 common stock purchase warrants as a bonus to our Chief Executive Officer, Dr. Shai Meretzki, in connection with the issuance of a Notice of Allowance by the United States Patent Office for our patent application number 09/890,401. Each warrant is exercisable until November 30, 2006 into one common share at a price of $0.30 per share. We have agreed to register the shares issuable on exercise of the warrants. The securities are to be issued in reliance on Regulation S.

2

MARKER FORMAT-SHEET="Head Major Left Bold-TNR" FSL="Workstation"

Item 8.01. Other Events

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation"

On January 4, 2005, 2005, the United States Patent office issued a Notice of Allowance of Patent for our patent application number 09/890,401. We consider the granting of this patent to be extremely important to our company as we will have United States patent protection for a fundamental invention which is the basis of our research and development. The patent is called “Method of Producing Undifferentiated Hematopoietic Stem Cells Using a Stationary Phase Plug Flow Bioreactor”. We are required to pay a fee by April 4, 2005 in order to have the patent granted. In connection with the issuance of the Notice of Allowance we have granted to Dr. Shai Meretzki, our Chief Executive Officer, a bonus payable in common shares and common share purchase warrants.

MARKER FORMAT-SHEET="Head Major Center Bold-TNR" FSL="Workstation"

SIGNATURES

MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation"

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARKER FORMAT-SHEET="Head Major Left Bold-TNR" FSL="Workstation"

PLURISTEM LIFE SYSTEMS, INC.

MARKER FORMAT-SHEET="Head Left-TNR" FSL="Default"

By: /s/ Shai Meretzki Shai Meretzki Date: March 23, 2005